SCHEMBL14330905

SCHEMBL14330905

CC(=O)Nc1ccc2sc(NC(=O)c3ccco3)nc2c1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 17/20 0.83
▸ NPC1 O15118 15/20 0.83
▸ ALDH1A1 P00352 3/20 0.76
▸ KDM4E B2RXH2 2/20 0.76
▸ POLB P06746 1/20 0.76
▸ HPGD P15428 1/20 0.76
▸ SMN1; SMN2 Q16637 5/20 0.69
▸ TP53 P04637 3/20 0.69
▸ PKM P14618 2/20 0.69
▸ APOBEC3A P31941 1/20 0.69
▸ APOBEC3G Q9HC16 1/20 0.69
▸ KMT2A Q03164 2/20 0.64
▸ MAPT P10636 2/20 0.64
▸ MEN1 O00255 1/20 0.64
▸ F2 P00734 1/20 0.61
▸ KLF5 Q13887 1/20 0.61
▸ CASP3 P42574 2/20 0.60
▸ SENP8 Q96LD8 2/20 0.60
▸ SENP7 Q9BQF6 2/20 0.60
▸ SENP6 Q9GZR1 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407604 0.91 RAB9A (1.00) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL16334021 0.83 RAB9A (0.87) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL3049831 0.80 RAB9A (0.77) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL2244452 0.78 RAB9A (1.00) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL28466466 0.76 RAB9A (0.74) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL19270403 0.76 RAB9A (0.71) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL10596662 0.76 RAB9A (0.65) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL22823075 0.76 RAB9A (1.00) RAB9ANPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL28466740 0.75 RAB9A (0.72) RAB9ANPC1ALDH1A1KDM4EPOLB
SCHEMBL28462117 0.75 RAB9A (0.72) RAB9ANPC1ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859597-B2 Compounds that enhance Atoh1 expression MASSACHUSETTS EYE & EAR INFIRMARY (US) 2014-10-14 — — US disclosed
US-20120328580-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120328580-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION DACH1, EZH1, CREBBP RAB9A 3293/4885NPC1 1018/4885ALDH1A1 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback